2023年2月12日 · Percutaneous transluminal coronary angioplasty (PTCA), or percutaneous coronary intervention (PCI), is a minimally invasive procedure to open blocked or stenosed coronary arteries, allowing unobstructed blood flow to the myocardium. The blockages occur because of lipid-rich plaque within the arteries, diminishing blood flow to the myocardium.

经皮冠状动脉介入治疗 （percutaneous coronary intervention，PCI）简称 经皮冠脉介入术[1]，是采用经皮穿刺借 心导管 技术，疏通狭窄甚至闭塞的 冠状动脉 管腔，从而改善 心肌 血流灌注 （英语：Perfusion） 的治疗方法。 借由心导管可送入球囊导管或其他相关器械，进行腔内成形术、腔内旋切术、腔内旋磨术、冠脉内支架置入术等。

2024年8月5日 · PTCA, or percutaneous transluminal coronary angioplasty, is a minimally invasive procedure that opens blocked coronary arteries to improve blood flow to the heart muscle. First, a local anesthesia numbs the groin area. Then, the doctor puts a needle into the femoral artery, the artery that runs down the leg.

急經皮冠狀動脈血管成形術（PTCA）和冠狀動脈繞道手術（CABG）挽救不少因急性冠脈綜合症 (ACS)患者的生命。 其適應症 (Indication)與禁忌症 (Contraindication)是必須熟記的，我們將這兩種手術方式以表格呈現，方便各位學習與記憶。

Percutaneous coronary interventions (PCI) include percutaneous transluminal coronary angioplasty (PTCA) with or without stent insertion. Primary indications are treatment of

Percutaneous Transluminal Coronary Angioplasty (PTCA) is a pioneering procedure that has revolutionised the treatment of coronary artery disease (CAD). It is commonly known as angioplasty. PTCA is a minimally invasive intervention designed to alleviate the blockages and restrictions within the coronary arteries.

粥狀硬化是冠狀動脈性心臟病 (CAD)的治療因經皮冠狀動脈介入治療術 (percutaneous coronary intervention, PCI)及冠狀動脈繞道術 (coronary artery bypass graft, CABG)之進展而有重大改變。 病人年齡、症狀、左心室功能、冠狀動脈粥狀硬化嚴重度可決定預後，也左右治療方式的選擇。 左冠狀動脈主幹狹窄 (LMD)及三條冠狀動脈狹窄 (3VD)之治療評估，以SYNTAX試驗最佳，ARTS II 試驗及紐約州登錄 ( New York State registries)也不錯。 此三份資料皆顯示以塗藥支架 (drug …

心冠狀動脈治療 (CAD) |主要適應症 1. 急性心肌梗塞 2. 慢性心絞痛或不穩定心絞痛,經過藥物治療能效果不佳且有明確心肌缺血證據 (抽血指數心肌酵素增加大於正常值) 3. 心電圖或運動心電圖測驗呈陽性者 4. 冠狀動脈再成形術 (PTCA)術後再狹窄者 5. 心律不整 6. 肺栓 ...

2024年7月15日 · When this occurs in the coronary arteries, it is referred to as coronary artery disease (CAD). In this context, percutaneous transluminal coronary angioplasty (PTCA) with a drug-eluting balloon (DEB) represents a novel treatment method and an alternative to other treatment methods, such as uncoated balloon catheters or stent implantations.

To evaluate the evidence of: 1. The use of Percutaneous Transluminary Coronary Angioplasty (PTCA) with elective stenting for patients with coronary artery disease (CAD). 2. The use of PTCA with stenting for sub-optimal PTCA results for patients with CAD. MEDLINE (1993 to April 1988) and Healthstar (1995 to March 1998) were searched.